Newsroom | 1996 results

SAN DIEGO--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (NYSE: IIPR) (“IIP” or the “Company”) announced today that its board of directors has declared a first quarter 2026 dividend of $1.90 per share of common stock, representing an annualized dividend of $7.60 per common share. Since its inception in 2016, the Company has paid $1.1 billion in common stock dividends to its shareholders. Additionally, IIP announced today that its board of directors has declared a regular quarterly div...

IRVINE, Calif.--(BUSINESS WIRE)--WM Technology, Inc. (“WM Technology” or the “Company”) (Nasdaq: MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced its financial results for the fourth quarter and year ended December 31, 2025. “2025 was another demanding year for the cannabis industry, with pressure in mature markets and cautious spending across much of the ecosystem,” said Doug Francis, CEO and Chairman of WM Technology. “Against that backd...

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the “Circular”) and related materials (the “Meeting Materials”) for its annual and special meeting (the “Meeting”) of the holders of its common shares (the “Shareholders”) to be held on March 30, 2026. The Circular is available under Organigram’s profile on SEDAR+ at ww...

CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers, and retailers of cannabis products in the United States, today announced that the ad hoc group of noteholders of the Company’s 9.25% Senior Secured Notes due December 31, 2028 and the 9.00% Senior Secured Convertible Notes due December 31, 2028 (collectively, the “Notes”), which are parties to t...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement...

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share1 is pleased to announce the launch of SHRED Shotz, a compact, single-serve 65ml cannabis beverage powered by FAST™, Organigram’s fast-acting nanoemulsion technology platform designed to deliver a 15-minute onset2. This launch reflects Organigram’s focus on differentiated innovation while leveraging the scale of SHRED, one of the Company’s best-...

スイス、リアッツィーノ--(BUSINESS WIRE)--（ビジネスワイヤ） -- Linneaは、当社のカンナビジオール（CBD）アイソレートが欧州薬局方適用性認証（CEP）を取得したことを発表しました。 CEPは、医薬品有効成分（API）の品質が欧州薬局方のモノグラフによって適切に管理されていることを証明するものであり、欧州における医薬品への使用における安全性、品質、適合性を保証します。 欧州医薬品品質庁（EDQM）が発行するCEPは、欧州市場における製品の安定性、安全性、規制コンプライアンスに対する独立した検証を意味します。これにより、規制当局による活性成分の詳細な評価が不要となるため、新薬の販売承認（MA）プロセスが簡素化されます。 今回のマイルストーン達成は当社にとって重要な成果であり、一貫性のある高品質なカンナビノイド成分を提供するという当社のコミットメントを強化するものです。この認証は、製品品質、規制コンプライアンス、製造ノウハウに関する保証を顧客およびパートナーに提供します。 「今回の成果は、品質、透明性、レギュラトリー・エクセレンスに対する当社の揺るぎない取り組み...

瑞士里亞齊諾--(BUSINESS WIRE)--(美國商業資訊)-- Linnea驕傲地宣布，其大麻二酚(CBD)純化物已獲得歐洲藥典適用性認證(CEP)。 CEP認證用於證明藥用活性成分(API)的品質受到歐洲藥典各論的充分管控，確保其在歐洲藥品中使用的安全性、品質與法規遵循。 由歐洲藥品與醫療保健品質管理局(EDQM)頒發的CEP證書，代表了對產品在歐洲市場的一致性、安全性和法規遵循的獨立驗證。這一認證相應簡化了新藥的上市授權(MA)流程，因為主管機關無需再對活性物質進行詳細評估。 這一里程碑是公司的重大成就，進一步強化了其對於提供始終如一的優質大麻素成分的承諾。該認證為客戶及合作夥伴提供了產品品質、法規遵循和生產專業能力方面的保障。 品質長兼技術負責人/專責人員Giorgia Tossi表示：「這一成就體現了我們對品質、透明度和監管卓越性的不懈追求。我們感謝團隊的付出，是他們的專注讓這一里程碑成為可能，也感謝始終信任我們的客戶。」 憑藉此項認證，Linnea進一步鞏固了其優質大麻素成分可靠供應商的地位，並繼續朝著提升全球法規遵循和品質領先地位的方向邁進。 關於LINNEA Li...

瑞士里亚齐诺--(BUSINESS WIRE)--(美国商业资讯)-- Linnea自豪地宣布，其大麻二酚(CBD)分离物已获得欧洲药典适用性认证(CEP)。 CEP认证用于证明药用活性成分(API)的质量受到欧洲药典各论的充分管控，确保其在欧洲药品中使用的安全性、质量与合规性。 由欧洲药品和医疗保健质量理事会(EDQM)颁发的CEP证书，代表了对产品在欧洲市场的一致性、安全性和监管合规性的独立验证。这一认证相应简化了新药的上市许可(MA)流程，因为监管机构无需再对活性物质进行详细评估。 这一里程碑是公司的重大成就，进一步强化了其对于提供始终如一的高品质大麻素成分的承诺。该认证为客户及合作伙伴提供了产品质量、监管合规和生产专业能力方面的保障。 首席质量官兼技术负责人/专责人员Giorgia Tossi表示：“这一成就体现了我们对质量、透明度和监管卓越性的不懈追求。我们感谢团队的付出，是他们的专注让这一里程碑成为可能，也感谢始终信任我们的客户。” 凭借此项认证，Linnea进一步巩固了其作为优质大麻素成分可靠供应商的地位，并继续朝着提升全球合规性和质量领先地位的方向迈进。 关于LINNE...

RIAZZINO, Suíça--(BUSINESS WIRE)--A Linnea tem o orgulho de anunciar que seu isolado de canabidiol (CBD) recebeu um Certificado de Conformidade com a Farmacopeia Europeia (CEP). O CEP serve para atestar que a qualidade de um ingrediente farmacêutico ativo (API) é adequadamente controlada pelas monografias da Farmacopeia Europeia, garantindo sua segurança, qualidade e conformidade para uso em produtos medicinais na Europa. Emitido pela Direção Europeia para a Qualidade dos Medicamentos e Cuidado...